• Publications
  • Influence
Scleromyxedema: a multicenter study of characteristics, comorbidities, course, and therapy in 30 patients.
The study confirms that scleromyxedema is a chronic and unpredictable disease with severe systemic manifestations leading to a guarded prognosis and the contention that intravenous immunoglobulin is a relatively effective and safe treatment is confirmed. Expand
Serology of Lupus Erythematosus: Correlation between Immunopathological Features and Clinical Aspects
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the aberrant production of a broad and heterogenous group of autoantibodies. Even though the presence of autoantibodies inExpand
Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication.
It is demonstrated that rosacea patients have a significantly higher SIBO prevalence than controls, and eradication of SIBO induced an almost complete regression of their cutaneous lesions and maintained this excellent result for at least 9 months. Expand
Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases.
Children and adults developed LS with analogous clinical and immunological features, however, the prevalence of LS variants differed between adult and pediatric populations, leading to different extracutaneous complications. Expand
Lupus erythematosus panniculitis (lupus profundus): Clinical, histopathological, and molecular analysis of nine cases
The main differential diagnosis is subcutaneous panniculitis‐like T‐cell lymphoma (SPTCL), which may be very difficult in cases in which involvement of the sub cutaneous fat is the only manifestation of the disease. Expand
Erythema gyratum repens is not an obligate paraneoplastic disease: a systematic review of the literature and personal experience
This data indicates that Erythema gyratum repens is a rare clinical entity that is considered to be an obligatory paraneoplastic disease and an underlying neoplasm can be detected in 82% of the cases. Expand
European dermatology forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis
The term ‘sclerosing diseases of the skin’ comprises specific dermatological entities which have fibrotic changes of the skin in common. These diseases mostly manifest in different clinical subtypesExpand
Sjögren's syndrome: a retrospective review of the cutaneous features of 93 patients by the Italian Group of Immunodermatology.
Xerosis is the most frequent and characteristic cutaneous manifestation of primary SS and is not linked to decreased sebaceous or sweat gland secretion, but more probably to a specific alteration of the protective function of the stratum corneum. Expand
Measuring the activity of the disease in patients with cutaneous lupus erythematosus
The SLAM system is useful in the monitoring of disease activity in patients with cutaneous LE, and over time, even L‐DLE patients may develop active disease. Expand
Atypical presentations of bullous pemphigoid: Clinical and immunopathological aspects.
The need to formulate universally recognized diagnostic criteria is increasingly evident, especially for atypical bullous pemphigoid, where direct immunofluorescence of perilesional skin and detection of circulating autoantibodies are mandatory in the diagnosis, especially when the clinical presentation is doubtful. Expand